Category: Accuray Inc.Syndicate content

Cyberknife: Man, that robot sure can dance

July 23, 2012 by MassDevice

See video

In this 2009 video from the American Society of Radiation Oncology annual meeting, employees from Sunnyvale, Calif.-based Accuray (NSDQ:ARAY) show off their dance moves.

Accuray nabs imaging systems maker Morphormics for $5.7M

July 16, 2012 by MassDevice staff

Radiosurgery devices company Accuray acquires medical imaging software systems maker Morphormics in a deal worth about $5.7 million.

Accuray logo

Accuray (NSDQ:ARAY) signed a definitive agreement to acquire medical imaging software systems maker Morphormics for $5.7 million, the company announced today.

Privately held Morphormics, founded by faculty of the University of North Carolina at Chapel Hill, develops software that recognizes and extracts anatomical structures from medical images.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

U.S. orthopedics on the upswing, analysts say | Wall Street Beat

June 27, 2012 by MassDevice staff

A new survey of U.S. hip and knee surgeons adds to Wall Street analysts' confidence that the orthopedics market is looking up.

MassDevice.com Wall Street Beat

Wall Street analysts are predicting with increasing confidence that the U.S. orthopedics market is on the upswing following an industry survey suggesting a coming increase in procedure volumes.

A MEDACorp orthopedics survey of 65 U.S. hip and knee surgeons found improvements in 12-month procedure volume expectations and increased patient willingness for surgery, according to an investment note from Leerink Swann analyst Richard Newitter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abiomed slides on reimbursement risk rumors | Wall Street Beat

May 22, 2012 by MassDevice staff

Abiomed says it hasn't heard of any Medicare reimbursement concerns, but a note from a Wall Street analyst sends shares down 6%.; also, Accuray teams up with the German Cancer Research Center; AngioDynamics closes the $335M Navilyst merger; athenahealth may be eyeing Epocrates; Covidien launches offering to pay off senior notes; plus, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

Abiomed (NSDQ:ABMD) slid 6% in late afternoon trading following a note from a Wall Street analyst warning about Medicare reimbursement concerns for the company's star Impella heart pumps.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray slides on lowered sales outlook | Earnings Roundup

May 9, 2012 by MassDevice staff

Shares of Accuray fall nearly 10% after the radiosurgery device maker lowers its sales forecast for the full year; plus, Q1 sales, earnings up for Henry Schein; LeMaitre Vascular's Q1 profits soar; Mindray's Q1 profits slide despite double-digit sales boost; Stereotaxis boosts Q1 sales, slashes losses; Steris profits spike in 2011; Symmetry Medical's Q1 bottom line plunges; Syneron boosts Q1 sales, losses widen; and more.

MassDevice.com news

Accuray (NSDQ:ARAY) shares are down nearly 10% today as investors react to wider 3rd-quarter losses and a lower sales forecast for the rest of fiscal 2012.

The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray slides on lowered sales outlook

May 9, 2012 by MassDevice staff

Shares of Accuray fall nearly 10% after the radiosurgery device maker lowers its sales forecast for the full year.

MassDevice.com news

Accuray (NSDQ:ARAY) shares are down nearly 10% today as investors react to wider 3rd-quarter losses and a lower sales forecast for the rest of fiscal 2012.

The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.

MassDevice.com +3 | The top 3 med-tech stories for May 7, 2012.

May 7, 2012 by MassDevice staff

Accuray CEO Euan Thomson tells MassDevice.com what it means to have a robotic device, the SEC probes Baxter on infusion pump recalls and St. Jude Medical's largest backer boosts stake by 30%.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp